Revisions in the International System for Staging Lung Cancer
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New International Staging System for Lung Cancer
Mountain, C. F. (1986) · Chest · doi:10.1378/chest.89.4_supplement.225s · Cited by 1,659
Self-citationDillman, R. O., Herndon, J., Seagren, S. L., Eaton, W. L., & Green, M. R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1210 · Cited by 923
The Effect of Surgical Treatment on Survival from Early Lung Cancer
Flehinger, B. J., Kimmel, M., & Melamed, M. R. (1992) · Chest · doi:10.1378/chest.101.4.1013 · Cited by 344
Harpole, D. H., Herndon, J. E., Wolfe, W. G., Iglehart, J. D., & Marks, J. R. (1995) · PubMed · Cited by 290
Cited by
Items 101–168 of 168
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
Taron, M., Rosell, R., Felip, E., Mendez, P., Souglakos, J., Ronco, M. S., Queralt, C., Majo, J., Sanchez, J. M., Sanchez, J. J., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh260 · Cited by 307
Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy
Martin, J., Ginsberg, R. J., Abolhoda, A., Bains, M. S., Downey, R. J., Korst, R. J., Weigel, T. L., Kris, M. G., Venkatraman, E. S., & Rusch, V. W. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(01)02995-2 · Cited by 305
Hofman, V., Ilie, M. I., Long, E., Selva, E., Bonnetaud, C., Molina, T., Vénissac, N., Mouroux, J., Vielh, P., & Hofman, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25819 · Cited by 304
Allgar, V. L., & Neal, R. D. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602587 · Cited by 303
Health state utilities in non–small cell lung cancer: An international study
Nafees, B., Lloyd, A. J., Dewilde, S., Rajan, N., & Lorenzo, M. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12477 · Cited by 303
Mac Manus, M. P., Hicks, R. J., Matthews, J. P., Hogg, A., McKenzie, A. F., Wirth, A., Ware, R. E., & Ball, D. L. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01477-8 · Cited by 297
Ohri, C. M., Shikotra, A., Green, R. H., Waller, D. A., & Bradding, P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00065708 · Cited by 296
Singhal, S., Vachani, A., Antin-Ozerkis, D., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2661 · Cited by 295
Survival After Recurrent Nonsmall-Cell Lung Cancer After Complete Pulmonary Resection
Sugimura, H., Nichols, F. C., Yang, P., Allen, M. S., Cassivi, S. D., Deschamps, C., Williams, B. A., & Pairolero, P. C. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.08.046 · Cited by 293
Selvaggi, G., Novello, S., Torri, V., Leonardo, E., De Giuli, P., Borasio, P., Mossetti, C., Ardissone, F., Lausi, P., & Scagliotti, G. V. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh011 · Cited by 292
Zhang, H., Wroblewski, K., Liao, S., Kampalath, R., Penney, B. C., Zhang, Y., & Pu, Y. (2013) · Academic Radiology · doi:10.1016/j.acra.2012.07.002 · Cited by 290
Liao, S., Penney, B. C., Wroblewski, K., Zhang, H., Simon, C. A., Kampalath, R., Shih, M.-C., Shimada, N., Chen, S., Salgia, R., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1934-6 · Cited by 287
Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer
Sanchez‐Palencia, A., Gomez‐Morales, M., Gomez‐Capilla, J. A., Pedraza, V., Boyero, L., Rosell, R., & Fárez‐Vidal, M. E. (2011) · International Journal of Cancer · doi:10.1002/ijc.25704 · Cited by 287
Fichtner, I., Rolff, J., Soong, R., Hoffmann, J., Hammer, S., Sommer, A., Becker, M., & Merk, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0138 · Cited by 286
Birim, Ö., Kappetein, A. P., Stijnen, T., & Bogers, A. J. J. C. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.06.041 · Cited by 284
Bremnes, R. M., Veve, R., Gabrielson, E., Hirsch, F. R., Baron, A., Bemis, L., Gemmill, R. M., Drabkin, H. A., & Franklin, W. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.159 · Cited by 281
Predictors of Survival in Patients With Bone Metastasis of Lung Cancer
Sugiura, H., Yamada, K., Sugiura, T., Hida, T., & Mitsudomi, T. (2008) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-007-0051-0 · Cited by 280
Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer
Barlési, F., Giaccone, G., Gallegos-Ruiz, M. I., Loundou, A., Span, S. W., Lefesvre, P., Kruyt, F. A. E., & Rodriguez, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2599 · Cited by 280
Visbal, A. L., Williams, B. A., Nichols, F. C., Marks, R. S., Jett, J. R., Aubry, M.-C., Edell, E. S., Wampfler, J. A., Molina, J. R., & Yang, P. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2003.11.021 · Cited by 279
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Sandoval, J., Mendez-Gonzalez, J., Nadal, E., Chen, G., Carmona, F. J., Sayols, S., Moran, S., Heyn, H., Vizoso, M., Gomez, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5516 · Cited by 278
ERCC1 Expression Is a Predictor of Survival in Resected Patients With Non-small Cell Lung Cancer
Simon, G. R., Sharma, S., Cantor, A., Smith, P., & Bepler, G. (2005) · Chest · doi:10.1378/chest.127.3.978 · Cited by 277
Altorki, N. K., Keresztes, R. S., Port, J. L., Libby, D. M., Korst, R. J., Flieder, D. B., Ferrara, C. A., Yankelevitz, D. F., Subbaramaiah, K., Pasmantier, M. W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.127 · Cited by 275
Delays in the Diagnosis and Treatment of Lung Cancer
Salomaa, E.-R., Sällinen, S., Hiekkanen, H., & Liippo, K. (2005) · Chest · doi:10.1378/chest.128.4.2282 · Cited by 274
van Rens, M. T. M., van den Bosch, J. M. M., Brutel de la Rivière, A., & Elbers, H. R. J. (2000) · Chest · doi:10.1378/chest.117.2.374 · Cited by 273
Blanchon, T., Bréchot, J.-M., Grenier, P. A., Ferretti, G. R., Lemarié, E., Milleron, B., Chagué, D., Laurent, F., Martinet, Y., Beigelman-Aubry, C., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.05.009 · Cited by 271
Exhaled biomarkers in lung cancer
Horváth, I., Lázár, Z., Gyulai, N., Kollai, M., & Losonczy, G. (2009) · European Respiratory Journal · doi:10.1183/09031936.00142508 · Cited by 268
Tang, X., Shigematsu, H., Bekele, B. N., Roth, J. A., Minna, J. D., Hong, W. K., Gazdar, A. F., & Wistuba, I. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1705 · Cited by 266
Fry, W. A., Phillips, J. L., & Menck, H. R. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991101)86:9<1867::aid-cncr31>3.0.co;2-9 · Cited by 263
The 7th lung cancer TNM classification and staging system: Review of the changes and implications
Mirsadraee, S. (2012) · World Journal of Radiology · doi:10.4329/wjr.v4.i4.128 · Cited by 261
Hirsch, F. R., Prindiville, S. A., Miller, Y. E., Franklin, W. A., Dempsey, E. C., Murphy, J. R., Bunn, P. A., & Kennedy, T. C. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.18.1385 · Cited by 257
Definition of gross tumor volume in lung cancer: inter-observer variability
Van de Steene, J., Linthout, N., de Mey, J., Vinh-Hung, V., Claassens, C., Noppen, M., Bel, A., & Storme, G. (2002) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(01)00453-4 · Cited by 255
Panel of Serum Biomarkers for the Diagnosis of Lung Cancer
Patz, E. F., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., & Herndon, J. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5392 · Cited by 247
Intraoperative Sentinel Lymph Node Mapping of the Lung Using Near-Infrared Fluorescent Quantum Dots
Soltesz, E. G., Kim, S., Laurence, R. G., DeGrand, A. M., Parungo, C. P., Dor, D. M., Cohn, L. H., Bawendi, M. G., Frangioni, J. V., & Mihaljevic, T. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.06.055 · Cited by 244
“Aside from the increased morbidity associated with this procedure, recurrent disease approaching 40% will develop in node-negative patients and they will die within 2 years [3].”
BackgroundSurgical treatment of hepatic and pulmonary metastases from colon cancer
Headrick, J. R., Miller, D. L., Nagorney, D. M., Allen, M. S., Deschamps, C., Trastek, V. F., & Pairolero, P. C. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)02522-4 · Cited by 241
“Thoracic lymph nodes were classified according to the International System for Staging Lung Cancer [18].”
MethodD'Amico, M., Massey, M., Herndon II, P., Moore, M.-B., & Harpole, D. H. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70294-1 · Cited by 233
Mujoomdar, A., Austin, J. H. M., Malhotra, R., Powell, C. A., Pearson, G. D. N., Shiau, M. C., & Raftopoulos, H. (2007) · Radiology · doi:10.1148/radiol.2423051707 · Cited by 228
Papi, A. (2004) · Thorax · doi:10.1136/thx.2003.018291 · Cited by 223
“Staging was done according to current TNM classification.”
MethodMcDonald, B., Spicer, J., Giannais, B., Fallavollita, L., Brodt, P., & Ferri, L. E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24409 · Cited by 222
“A high proportion of patients harbor metastasis to regional lymph nodes upon presentation, and over half of all patients who undergo curative intent surgical resection of the lung will develop metastatic recurrence.(2) The liver is a common site of metastasis for lung cancer, with autopsy studies showing hepatic metas…”
Backgroundp53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective Study
Ahrendt, S. A., Hu, Y., Buta, M., McDermott, M. P., Benoit, N., Yang, S. C., Wu, L., & Sidransky, D. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.961 · Cited by 222
Eloubeidi, M. A., Cerfolio, R. J., Chen, V. K., Desmond, R., Syed, S., & Ojha, B. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.06.089 · Cited by 216
Long-term results of combined-modality therapy in resectable non-small-cell lung cancer.
Martin, J., Ginsberg, R. J., Venkatraman, E. S., Bains, M. S., Downey, R. J., Korst, R. J., Kris, M. G., & Rusch, V. W. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.092 · Cited by 195
Kaira, K., Higuchi, T., Naruse, I., Arisaka, Y., Tokue, A., Altan, B., Suda, S., Mogi, A., Shimizu, K., Sunaga, N., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3806-1 · Cited by 195
Limited Resection for the Treatment of Patients With Stage IA Lung Cancer
Wisnivesky, J. P., Henschke, C. I., Swanson, S., Yankelevitz, D. F., Zulueta, J., Marcus, S., & Halm, E. A. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181c0e5f3 · Cited by 195
“Although the prognosis of patients with non-small cell lung cancer (NSCLC) remains poor, surgically resected patients with stage IA disease have 5-year survival rates as high as 70% and the best chance to be cured.(2) The standard treatment for stage I NSCLC is lobectomy with mediastinal lymph node sampling or dissect…”
BackgroundResultFrüh, M., Rolland, E., Pignon, J.-P., Seymour, L., Ding, K., Tribodet, H., Winton, T., Le Chevalier, T., Scagliotti, G. V., Douillard, J. Y., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.2727 · Cited by 193
“40% to 50% in stage II, and only 25% to 30% in patients with stage IIIA tumors.(6) The 1995 meta-”
BackgroundBryant, A., & Cerfolio, R. J. (2007) · Chest · doi:10.1378/chest.07-0442 · Cited by 190
Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions
Tang, X., Liu, D., Shishodia, S., Ozburn, N., Behrens, C., Lee, J. J., Hong, W. K., Aggarwal, B. B., & Wistuba, I. I. (2006) · Cancer · doi:10.1002/cncr.22315 · Cited by 190
Qiao, G.-B., Wu, Y.-L., Yang, X.-N., Zhong, W.-Z., Xie, D., Guan, X.-Y., Fischer, D., Kolberg, H.-C., Kruger, S., & Stuerzbecher, H.-W. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602665 · Cited by 186
Dome, B., Timar, J., Dobos, J., Meszaros, L., Raso, E., Paku, S., Kenessey, I., Ostoros, G., Magyar, M., Ladanyi, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4654 · Cited by 184
“Internationale Contra Cancrum tumor-node-metastasis classification (16).”
The Cost-Effectiveness of Low-Dose CT Screening for Lung Cancer*
Wisnivesky, J. P., Mushlin, A. I., Sicherman, N., & Henschke, C. (2003) · Chest · doi:10.1378/chest.124.2.614 · Cited by 184
Mamon, H. J., Yeap, B. Y., Jänne, P. A., Reblando, J., Shrager, S., Jaklitsch, M. T., Mentzer, S., Lukanich, J. M., Sugarbaker, D. J., Baldini, E. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.123 · Cited by 184
İlie, M., Mazure, N. M., Hofman, V, Ammadi, R. E., Ortholan, C., Bonnetaud, C., Havet, K., Venissac, N., Mograbi, B., Mouroux, J., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605690 · Cited by 184
“The tumours were staged according to the international tumour-node-metastasis system (Mountain, 1997). The median follow-up at the time of analysis was 35 months (3–102 months) according to the method of Schemper and Smith, (1996). Among these patients, 122 of 555 (22%) died of lung cancer.”
Kersting, M., Friedl, C., Kraus, A., Behn, M., Pankow, W., & Schuermann, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3221 · Cited by 181
Electronic nose: a non-invasive technology for breath analysis of diabetes and lung cancer patients
Behera, B., Joshi, R., Anil Vishnu, G. K., Bhalerao, S., & Pandya, H. J. (2019) · Journal of Breath Research · doi:10.1088/1752-7163/aafc77 · Cited by 179
Ajona, D., Pajares, M. J., Corrales, L., Perez-Gracia, J. L., Agorreta, J., Lozano, M. D., Torre, W., Massion, P. P., de-Torres, J. P., Jantus-Lewintre, E., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt205 · Cited by 176
Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung
Pelosi, G., Fraggetta, F., Pasini, F., Maisonneuve, P., Sonzogni, A., Iannucci, A., Terzi, A., Bresaola, E., Valduga, F., Lupo, C., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200103000-00011 · Cited by 175
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
Pelosi, G., Pastorino, U., Pasini, F., Maissoneuve, P., Fraggetta, F., lannucci, A., Sonzogni, A., De Manzoni, G., Terzi, A., Durante, E., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600731 · Cited by 174
Meloni, F., Morosini, M., Solari, N., Passadore, I., Nascimbene, C., Novo, M., Ferrari, M., Cosentino, M., Marino, F., Pozzi, E., et al. (2006) · Human Immunology · doi:10.1016/j.humimm.2005.11.005 · Cited by 169
Okada, M., Yamagishi, H., Satake, S., Matsuoka, H., Miyamoto, Y., Yoshimura, M., & Tsubota, N. (2000) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(00)70018-3 · Cited by 167
Trousse, D., Barlesi, F., Loundou, A., Tasei, A. M., Doddoli, C., Giudicelli, R., Astoul, P., Fuentes, P., & Thomas, P. (2007) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.01.012 · Cited by 167
Vesselle, H., Salskov, A., Turcotte, E., Wiens, L., Schmidt, R., Jordan, C. D., Vallières, E., & Wood, D. E. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818307a7 · Cited by 165
Huang, C.-L., Liu, D., Nakano, J., Ishikawa, S., Kontani, K., Yokomise, H., & Ueno, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2871 · Cited by 165
GUZELANT, A., GOKSEL, T., OZKOK, S., TASBAKAN, S., AYSAN, T., & BOTTOMLEY, A. (2004) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2003.00435.x · Cited by 157
Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer
Walker, M. S., Vidrine, D. J., Gritz, E. R., Larsen, R. J., Yan, Y., Govindan, R., & Fisher, E. B. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0509 · Cited by 147
Wu, Y., Li, P., Zhang, H., Shi, Y., Wu, H., Zhang, J., Qian, Y., Li, C., & Yang, J. (2013) · International Journal of Cancer · doi:10.1002/ijc.27779 · Cited by 129
Takenaka, K., Ishikawa, S., Kawano, Y., Yanagihara, K., Miyahara, R., Otake, Y., Morioka, Y., Takahashi, C., Noda, M., Wada, H., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.028 · Cited by 104
“P-stage was reevaluated according to the current TNM classification (revised in 1997) [15].”
MethodDifferences in outcomes between younger and older patients with non-small cell lung cancer
Bryant, A. S., & Cerfolio, R. J. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.01.031 · Cited by 67
Enatsu, S., Iwasaki, A., Shirakusa, T., Hamasaki, M., Nabeshima, K., Iwasaki, H., Kuroki, M., & Kuroki, M. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.03.027 · Cited by 42
Rangel, M. L., Milbury, K., Kayser, K., Ripley, R. T., Kvale, E., & Badr, H. (2024) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2024.100736 · Cited by 6
Metadata
- Authors
- Mountain, C. F.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1997-06
- Volume
- 111
- Issue
- 6
- Pages
- 1710-1717
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W1993312546
- Cited by
- 4,565
- References
- 4
- FWCI
- 114.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.